CClinicalTrials.gg
CompletedNCT04625816Updated Jan 13, 2021

Comparison of Core Muscle Asymmetry Using Spine Balance 3D in Patients With Arthroscopic Shoulder Surgery

An interventional study of whole body tilt device (Spine Balance 3D) in Muscle Disorder, Postoperative Pain and Shoulder Injuries, sponsored by Sahmyook University. Completed at 1 site in Korea, Republic of. Open to participants aged 26 Years to 66 Years. Per ClinicalTrials.gov, last updated 2021-01-13.

Sponsored by Sahmyook University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
55
Allocation
Not applicable
Ages
26 Years to 66 Years
Sex
All
01

Study summary

This study is an observational cross-sectional study. Post-operative patients need an immobilization period for a certain period of time after surgery. Kinetic chain changes due to immobilization can affect the symmetry of the core muscle. Therefore, in this study, core muscle asymmetry (CMA) is measured using a whole body tilt device for inpatients who have undergone arthroscopic shoulder surgery. We would like to make a clinical suggestion for post-operative rehabilitation by identifying the characteristics of CMA according to the left or right site.

02

Conditions studied

  • Muscle Disorder
  • Postoperative Pain
  • Shoulder Injuries
  • Immobilization
  • Asymmetric Limb Muscle Stiffness
03

In context

Muscular Diseases

280 studies on the registry are indexed under Muscular Diseases; 63 are open to participants now.

This study's enrollment of 55 is above the median of 34 across 157 interventional studies indexed under Muscular Diseases.

Browse Muscular Diseases studies →

Lead sponsor

Sahmyook University is the lead sponsor of 42 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
26 Years to 66 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • arthroscopic shoulder surgery
  • limit of motion due to shoulder pain

Exclusion criteria

Exclusion Criteria:

  • orthopedic surgery or other medical history in the lower extremities
  • neurological history or are taking related medications
  • chronic headache or disease related to the inner ear
  • cardiovascular disease that may affect balance ability or take related medications
  • acute dizziness
  • when performing other balance training
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
55 participants (actual)

Study arms

  • Experimental
    Arthroscopic shoulder surgery patients

    Device: whole body tilt device (Spine Balance 3D)

Interventions

  • Devicewhole body tilt device (Spine Balance 3D)

    The symmetry of the deep muscle was evaluated using a whole body tilt device (Spine Balance 3D, Cyber Medic Co., Ltd., Korea). Spine Balance 3D can evaluate the maintenance strength and maximum strength of the core muscles, and perform a personalized core muscle training program based on the evaluated results.

06

What researchers measure

Primary outcomes

  1. direction core muscle ratio (DCMR)

    DCMR was calculated as a percentage of time located in each direction.

    Time frame: 1 Day

  2. core muscle state ratio (CMSR)

    CMSR was calculated as a percentage of the value compared to the reference data of healthy adults.

    Time frame: 1 Day

07

Study locations

1 site
  • Sahmyook University
    Seoul, 01795, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: Undecided — I plan to decide after the study is over.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04625816
Lead sponsor
Sahmyook University
Responsible party
Hyun-Joong Kim (Principal Investigator, Sahmyook University) — Principal investigator
First posted
Nov 12, 2020
Start date
Nov 28, 2020
Primary completion
Dec 12, 2020
Completion
Dec 19, 2020
Last update
Jan 13, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion